Matthew B. Stern

20.5k total citations · 1 hit paper
100 papers, 7.8k citations indexed

About

Matthew B. Stern is a scholar working on Neurology, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Matthew B. Stern has authored 100 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Neurology, 26 papers in Cognitive Neuroscience and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Matthew B. Stern's work include Parkinson's Disease Mechanisms and Treatments (74 papers), Neurological disorders and treatments (54 papers) and Neurobiology of Language and Bilingualism (13 papers). Matthew B. Stern is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (74 papers), Neurological disorders and treatments (54 papers) and Neurobiology of Language and Bilingualism (13 papers). Matthew B. Stern collaborates with scholars based in United States, Canada and Austria. Matthew B. Stern's co-authors include Daniel Weintraub, Andrew Siderowf, John E. Duda, Howard I. Hurtig, Paul J. Moberg, C. Warren Olanow, Kapil D. Sethi, Ira R. Katz, Marc N. Potenza and Amy Colcher and has published in prestigious journals such as Neurology, Annals of Neurology and The Lancet Neurology.

In The Last Decade

Matthew B. Stern

99 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The scientific and clinical basis for the treatment of Parkinson disease (2009)

2009 644 citations Matthew B. Stern, Kapil D. Sethi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew B. Stern United States	49	5.8k	1.7k	1.7k	1.1k	825	100	7.8k
Laura Marsh United States	51	5.4k 0.9×	1.7k 1.0×	2.4k 1.4×	2.1k 1.9×	726 0.9×	138	9.0k
Kathy Dujardin France	47	4.9k 0.8×	1.4k 0.8×	2.9k 1.7×	1.4k 1.3×	678 0.8×	176	7.7k
Gabriella Santangelo Italy	51	5.0k 0.9×	859 0.5×	2.3k 1.4×	1.9k 1.8×	609 0.7×	240	8.2k
Paul J. Moberg United States	50	2.1k 0.4×	886 0.5×	1.8k 1.0×	2.1k 1.9×	600 0.7×	133	7.9k
John E. Duda United States	38	5.7k 1.0×	1.6k 0.9×	1.2k 0.7×	1.6k 1.5×	952 1.2×	61	8.0k
Sharon Abrahams United Kingdom	53	5.9k 1.0×	928 0.5×	2.2k 1.3×	1.7k 1.6×	819 1.0×	169	10.3k
Carl E Clarke United Kingdom	54	9.3k 1.6×	2.4k 1.4×	1.7k 1.0×	2.2k 2.0×	804 1.0×	160	11.9k
John N. Caviness United States	48	5.9k 1.0×	1.8k 1.0×	1.4k 0.8×	1.2k 1.1×	966 1.2×	181	8.5k
Mark Stacy United States	47	6.0k 1.0×	2.5k 1.4×	1.1k 0.6×	752 0.7×	443 0.5×	110	8.0k
Stéphane Thobois France	44	4.5k 0.8×	2.0k 1.1×	1.4k 0.8×	347 0.3×	984 1.2×	182	6.1k

Countries citing papers authored by Matthew B. Stern

Since Specialization

Citations

This map shows the geographic impact of Matthew B. Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Stern more than expected).

Fields of papers citing papers by Matthew B. Stern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew B. Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Stern. The network helps show where Matthew B. Stern may publish in the future.

Co-authorship network of co-authors of Matthew B. Stern

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew B. Stern. A scholar is included among the top collaborators of Matthew B. Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew B. Stern. Matthew B. Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chahine, Lana M., Matthew B. Stern, & Alice Chen‐Plotkin. (2013). Blood-based biomarkers for Parkinson's disease. Parkinsonism & Related Disorders. 20. S99–S103. 117 indexed citations

Ross, Owen A., Corey T. McMillan, Michael Dreyfuss, et al.. (2013). Impairment of script comprehension in Lewy body spectrum disorders. Brain and Language. 125(3). 330–343. 4 indexed citations

Stern, Matthew B., Anthony E. Lang, & Werner Poewe. (2012). Toward a redefinition of Parkinson's disease. Movement Disorders. 27(1). 54–60. 116 indexed citations

Siderowf, Andrew, Danna Jennings, Shirley Eberly, et al.. (2012). Impaired olfaction and other prodromal features in the Parkinson At‐Risk Syndrome study. Movement Disorders. 27(3). 406–412. 144 indexed citations

Akhtar, Rizwan & Matthew B. Stern. (2012). New concepts in the early and preclinical detection of Parkinson’s disease: therapeutic implications. Expert Review of Neurotherapeutics. 12(12). 1429–1438. 20 indexed citations

Rao, Hengyi, Eugenia Mamikonyan, John A. Detre, et al.. (2010). Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Movement Disorders. 25(11). 1660–1669. 127 indexed citations

Kleiner‐Fisman, Galit, Matthew B. Stern, & David N. Fisman. (2010). Health-Related Quality of Life in Parkinson disease: Correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans. Health and Quality of Life Outcomes. 8(1). 91–91. 33 indexed citations

Garg, Shalini, et al.. (2009). Involuntary emotional expression disorder (IEED) in Parkinson's disease. Parkinsonism & Related Disorders. 15(7). 511–515. 14 indexed citations

Weintraub, Daniel, Judy A. Shea, Kelly E. Lyons, et al.. (2009). Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease. Movement Disorders. 24(10). 1461–1467. 390 indexed citations

10.

Mamikonyan, Eugenia, Paul J. Moberg, Andrew Siderowf, et al.. (2008). Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism & Related Disorders. 15(3). 226–231. 146 indexed citations

11.

Noorigian, Joseph V., Keith Robinson, David N. Fisman, et al.. (2007). Falling in Parkinson Disease. American Journal of Physical Medicine & Rehabilitation. 86(8). 621–632. 62 indexed citations

12.

Liang, Grace, Kelvin L. Chou, Gordon H. Baltuch, et al.. (2006). Long-Term Outcomes of Bilateral Subthalamic Nucleus Stimulation in Patients with Advanced Parkinson’s Disease. Stereotactic and Functional Neurosurgery. 84(5-6). 221–227. 69 indexed citations

13.

Lyons, Kelly E., Rajesh Pahwa, Cynthia Comella, et al.. (2003). Benefits and Risks of Pharmacological Treatments for Essential Tremor. Drug Safety. 26(7). 461–481. 68 indexed citations

14.

Simuni, Tanya, Jurg L. Jaggi, Howard I. Hurtig, et al.. (2002). Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. Journal of neurosurgery. 96(4). 666–672. 121 indexed citations

15.

Grossman, Murray, et al.. (2001). Dopamine supports sentence comprehension in Parkinson’s Disease. Journal of the Neurological Sciences. 184(2). 123–130. 52 indexed citations

16.

Duda, John E., Benoit I. Giasson, Qiping Chen, et al.. (2000). Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies. American Journal Of Pathology. 157(5). 1439–1445. 226 indexed citations

17.

Grossman, Murray, et al.. (2000). Cognitive Resource Limitations during Sentence Comprehension in Parkinson's Disease. Brain and Language. 73(1). 1–16. 63 indexed citations

18.

Stern, Matthew B., et al.. (1999). Does Levodopa Accelerate Parkinson??s Disease?. Drugs & Aging. 14(6). 399–408. 27 indexed citations

19.

Carvell, Susan, et al.. (1992). Sentence comprehension in Parkinson's disease: The role of attention and memory. Brain and Language. 42(4). 347–384. 165 indexed citations

20.

Stern, Matthew B.. (1991). Head trauma as a risk factor for Parkinson's disease. Movement Disorders. 6(2). 95–97. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact